These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 7457647)

  • 21. Levo-alpha-acetylmethadol (LAAM) versus methadone: treatment retention and opiate use.
    Longshore D; Annon J; Anglin MD; Rawson RA
    Addiction; 2005 Aug; 100(8):1131-9. PubMed ID: 16042643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma l-alpha-Acetylmethadol (LAAM) after acute and chronic administration.
    Henderson GL; Wilson BK; Lau DH
    Clin Pharmacol Ther; 1977 Jan; 21(1):16-25. PubMed ID: 832446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Symptom complaints of patients maintained on methadone, LAAM (methadyl acetate), and naltrexone at different times in their addiction careers.
    Judson BA; Goldstein A
    Drug Alcohol Depend; 1982; 10(2-3):269-82. PubMed ID: 7166139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levo-alpha-acetylmethadol (LAAM): clinical, research, and policy issues of a new pharmacotherapy for opioid addiction.
    Prendergast ML; Grella C; Perry SM; Anglin MD
    J Psychoactive Drugs; 1995; 27(3):239-47. PubMed ID: 8594167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early clinical studies of levo-alpha acetylmethadol (LAAM): an opiate for use in the medical treatment of chronic heroin dependence.
    Blaine JD
    NIDA Res Monogr; 1978; (19):249-59. PubMed ID: 106289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. l-alpha-Acetylmethadol, l-alpha-acetyl-N-normethadol and l-alpha-acetyl-N,N-dinormethadol: comparisons with morphine and methadone in suppression of the opioid withdrawal syndrome in the dog.
    Vaupel DB; Jasinski DR
    J Pharmacol Exp Ther; 1997 Nov; 283(2):833-42. PubMed ID: 9353405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential electroencephalographic and behavioral cross tolerance to morphine and methadone in the l-alpha-acetylmethadol (LAAM)-maintained rat.
    Lukas SE; Moreton JE; Khazan N
    J Pharmacol Exp Ther; 1982 Mar; 220(3):561-7. PubMed ID: 7199573
    [No Abstract]   [Full Text] [Related]  

  • 28. How effective is LAAM treatment? Clinical comparison with methadone.
    Zangwell BC; McGahan P; Dorozynsky L; McLellan AT
    NIDA Res Monogr; 1986; 67():249-55. PubMed ID: 3092073
    [No Abstract]   [Full Text] [Related]  

  • 29. LAAM (l-alpha-acetylmethadol) study in St. Louis.
    Parwatikar S; Crawford J; Unverdi C
    Am J Drug Alcohol Abuse; 1975; 2(3-4):341-52. PubMed ID: 1227295
    [No Abstract]   [Full Text] [Related]  

  • 30. The use of l-alpha-acetylmethadol in treatment of heroin addiction: an open study.
    Wilson BK; Spannagel V; Thomson CP
    Int J Addict; 1976; 11(6):1091-100. PubMed ID: 1025033
    [No Abstract]   [Full Text] [Related]  

  • 31. Heroin discriminative stimulus effects of methadone, LAAM and other isomers of acetylmethadol in rats.
    Newman JL; Vann RE; May EL; Beardsley PM
    Psychopharmacology (Berl); 2002 Oct; 164(1):108-14. PubMed ID: 12373424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized trial comparing levo-alpha acetylmethadol with methadone maintenance for patients in primary care settings in Australia.
    Ritter AJ; Lintzeris N; Clark N; Kutin JJ; Bammer G; Panjari M
    Addiction; 2003 Nov; 98(11):1605-13. PubMed ID: 14616187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relative potency of levo-alpha-acetylmethadol and methadone in humans under acute dosing conditions.
    Eissenberg T; Stitzer ML; Bigelow GE; Buchhalter AR; Walsh SL
    J Pharmacol Exp Ther; 1999 May; 289(2):936-45. PubMed ID: 10215673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of levo-alpha-acetylmethadol and its metabolites on schedule-controlled behavior in the pigeon.
    McGivney WT; McMillan DE
    J Pharmacol Exp Ther; 1981 Feb; 216(2):299-305. PubMed ID: 7463351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Every-other-day acetylmethadol disturbs circadian cycles of human motility.
    Crowley TJ; Jones RH; Hydinger-Macdonald MJ; Lingle JR; Wagner JE; Egan DJ
    Psychopharmacology (Berl); 1979 Apr; 62(2):151-5. PubMed ID: 111279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of 1-alpha-acetyl-methadol (LAAM) as compared to methadone in the maintenance and detoxification of young heroin addicts. 1973 [proceedings].
    Lehmann WX
    NIDA Res Monogr; 1976 Jul; (8):82-3. PubMed ID: 792705
    [No Abstract]   [Full Text] [Related]  

  • 37. Levo-alpha-acetylmethadol (LAAM) in the treatment of heroin addicts. I. Dosage schedule for induction and stabilization.
    Judson BA; Goldstein A
    Drug Alcohol Depend; 1979 Nov; 4(6):461-6. PubMed ID: 533680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opioid agonist maintenance for probationers: patient-level predictors of treatment retention, drug use, and crime.
    Gryczynski J; Kinlock TW; Kelly SM; O'Grady KE; Gordon MS; Schwartz RP
    Subst Abus; 2012; 33(1):30-9. PubMed ID: 22263711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New drugs for substitution treatment of opioid dependence. Buprenorphine and 1-alpha-acetylmethadol (LAAM) ].
    Petersen H; Skauge L; Svejsø J; Ege PP
    Ugeskr Laeger; 2000 Nov; 162(48):6553-6. PubMed ID: 11187226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis.
    Farré M; Mas A; Torrens M; Moreno V; Camí J
    Drug Alcohol Depend; 2002 Feb; 65(3):283-90. PubMed ID: 11841899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.